dc.contributor.author | Beedie, Shaunna L. | |
dc.contributor.author | Peer, Cody J. | |
dc.contributor.author | Pisle, Steven | |
dc.contributor.author | Gardner, Erin R. | |
dc.contributor.author | Mahony, Chris | |
dc.contributor.author | Barnett, Shelby | |
dc.contributor.author | Ambrozak, Agnieszka | |
dc.contributor.author | Gütschow, Michael | |
dc.contributor.author | Chau, Cindy H. | |
dc.contributor.author | Vargesson, Neil | |
dc.contributor.author | Figg, William D | |
dc.date.accessioned | 2016-09-30T23:01:59Z | |
dc.date.available | 2016-09-30T23:01:59Z | |
dc.date.issued | 2015-10 | |
dc.identifier.citation | Beedie , S L , Peer , C J , Pisle , S , Gardner , E R , Mahony , C , Barnett , S , Ambrozak , A , Gütschow , M , Chau , C H , Vargesson , N & Figg , W D 2015 , ' Anticancer Properties of a Novel Class of Tetrafluorinated Thalidomide Analogues ' , Molecular Cancer Therapeutics , vol. 14 , no. 10 , pp. 2228-2237 . https://doi.org/10.1158/1535-7163.MCT-15-0320 | en |
dc.identifier.other | PURE: 54304947 | |
dc.identifier.other | PURE UUID: aca8e1f6-d37c-40aa-aec8-4029b1ab287d | |
dc.identifier.other | Scopus: 84946762788 | |
dc.identifier.other | ORCID: /0000-0001-8027-114X/work/22441806 | |
dc.identifier.other | PubMed: 26269604 | |
dc.identifier.uri | http://hdl.handle.net/2164/7555 | |
dc.description | The authors thank Scott McMenemy for carrying out preliminary, early studies looking at effects of Gu compounds upon chicken embryology, as well as Charles D. Crowe, Jeffrey E. Roth, and Adam C. Rolt for critical comments on the article. fli1:EGFP zebrafish were obtained from the Zebrafish International Research Center (27). mpo:GFP zebrafish [also termed Tg(MPO:GFP)114] zebrafish were obtained from Dr. Stephen Renshaw, University of Sheffield (Sheffield, South Yorkshire, UK; ref. 29). | en |
dc.format.extent | 10 | |
dc.language.iso | eng | |
dc.relation.ispartof | Molecular Cancer Therapeutics | en |
dc.rights | This is the author's version of a paper accepted for publication in Molecular Cancer Therapeutics | en |
dc.subject | SDG 3 - Good Health and Well-being | en |
dc.subject | R Medicine | en |
dc.subject | Wellcome Trust | en |
dc.subject | 098252/Z/12/Z | en |
dc.subject.lcc | R | en |
dc.title | Anticancer Properties of a Novel Class of Tetrafluorinated Thalidomide Analogues | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Medical Sciences | en |
dc.contributor.institution | University of Aberdeen.Medical Sciences - Cell, Developmental and Cancer Biology | en |
dc.contributor.institution | University of Aberdeen.Institute of Medical Sciences | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Postprint | en |
dc.identifier.doi | https://doi.org/10.1158/1535-7163.MCT-15-0320 | |
dc.date.embargoedUntil | 2016-10-01 | |
dc.identifier.vol | 14 | en |
dc.identifier.iss | 10 | en |